Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
CorWave, founded in 2011 and headquartered in Clichy, France, is a medical technology company specializing in the development of cardiac assist devices. Their primary focus is on creating innovative solutions for heart failure patients, with their flagship product being a wave membrane pump designed to mimic the natural pulse and blood flow of a healthy heart. This technology aims to enhance the effectiveness of existing left ventricular assist devices, potentially improving patient outcomes.
Since its inception, CorWave has made significant strides in the medical technology sector, raising a total of $116.62 million in funding. This substantial investment demonstrates investor confidence in the company's potential and innovative approach to cardiac care. CorWave's unique technology and focus on addressing critical healthcare needs position it as a noteworthy player in the medical device industry.
As of now, there is no concrete information available regarding CorWave's IPO prospects. The company has not made any official announcements about plans to go public, and we have not found any credible reports or rumors suggesting an imminent IPO. It's important to note that the decision to pursue an initial public offering depends on various factors, including market conditions, company readiness, and strategic objectives.
For potential investors interested in CorWave, it's advisable to keep an eye on official company announcements and reputable financial news sources for any updates on the company's funding status or potential IPO plans. As with any investment opportunity, thorough research and due diligence are essential before making any financial decisions.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While CorWave's IPO prospects remain uncertain, investors interested in innovative medical technology companies don't have to wait. At Linqto, we offer members access to interests in promising pre-IPO private companies, including potential leaders in the healthcare and medical device sectors. Our platform allows you to diversify your portfolio with lower minimum investments, potentially benefiting from the growth of emerging industry pioneers like CorWave before they go public.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
